| NDC Code | 70461-319-03 |
|---|
| Package Description | 10 SYRINGE, GLASS in 1 CARTON (70461-319-03) > .5 mL in 1 SYRINGE, GLASS (70461-319-04) |
|---|
| Product NDC | 70461-319 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flucelvax Quadrivalent |
|---|
| Proprietary Name Suffix | (prefilled Syringe) |
|---|
| Non-Proprietary Name | Influenza A Virus A/idaho/07/2018 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated, Influenza A Virus A/indiana/08/2018 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/inftt-16-0610/2016 Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/iowa/06/2017 Antigen (mdck Cell Derived, Propiolactone Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20160523 |
|---|
| End Marketing Date | 20200731 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125408 |
|---|
| Manufacturer | Seqirus, Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/IDAHO/07/2018 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED; INFLUENZA A VIRUS A/INDIANA/08/2018 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/IOWA/06/2017 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|